In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. A light and electron microscopic study
- PMID: 7195245
In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. A light and electron microscopic study
Abstract
The effects of 2-cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one (praziquantel, EMBAY 8440, Biltricide) on Schistosoma mansoni was studied in vivo and in vitro by means of electron microscopy. It was found that 1. worms were contracted and became dislodged to the liver; 2. intensive vacuolisation occurred at distinct sites of the tegument within 5 min; 3. the surface coat remained unaffected; 4. host cells of the defense system attached to the tegumental vacuoles and started to penetrate into the interior of the parasites about 4 h after treatment; 5. only oral treatment of mice with a curative dose was lethal for the parasites, whereas worms treated with a subcurative dose recovered from the phenomena described above; 6. worms were fixed by fibroblasts to the walls of blood vessels 17 h after treatment; 7. the interior of the parasites was destroyed by host cells - especially eosinophilic granulocytes - while their exterior structures remained unchanged for some time; 8. worms disintegrated completely in the centre of typical granulomas as seen on days 14 and 18 after treatment; at this time only residues of the parasites were still recognisable within necrotic zones.
Similar articles
-
A summary of the efficacy of praziquantel against schistosomes in animal experiments and notes on its mode of action.Arzneimittelforschung. 1981;31(3a):538-41. Arzneimittelforschung. 1981. PMID: 7016122 Review.
-
The effect of praziquantel on Schistosoma haematobium, S. japonicum and S. mansoni in primates.Arzneimittelforschung. 1981;31(3a):542-4. Arzneimittelforschung. 1981. PMID: 7195244
-
Preliminary observations on the treatment of Schistosomiasis mansoni with praziquantel in Kenya.Arzneimittelforschung. 1981;31(3a):594-6. Arzneimittelforschung. 1981. PMID: 7195253
-
Praziquantel: a new schistosomicide against Schistosoma mansoni.Arzneimittelforschung. 1981;31(3a):592-4. Arzneimittelforschung. 1981. PMID: 7195252
-
Schistosoma mansoni: the effects of a subcurative dose of praziquantel on the ultrastructure of worms in vivo.Z Parasitenkd. 1983;69(1):73-90. doi: 10.1007/BF00934012. Z Parasitenkd. 1983. PMID: 6340360 Review.
Cited by
-
Experimental chemotherapy of Schistosoma mansoni with praziquantel and oxamniquine: differential effect of single or combined formulations of drugs on various strains and on both sexes of the parasite.Parasitol Res. 1992;78(8):648-54. doi: 10.1007/BF00931515. Parasitol Res. 1992. PMID: 1480600
-
A Review of Nanotechnology for Targeted Anti-schistosomal Therapy.Front Bioeng Biotechnol. 2020 Jan 31;8:32. doi: 10.3389/fbioe.2020.00032. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32083071 Free PMC article. Review.
-
Parasitological evaluation of Ro 15-9268, a 9-acridanone-hydrazone derivative against Schistosoma mansoni in mice, and observations on changes in serum enzyme levels.Parasitol Res. 2014 Jan;113(1):437-46. doi: 10.1007/s00436-013-3673-z. Epub 2013 Nov 22. Parasitol Res. 2014. PMID: 24265055
-
New insight into praziquantel against various developmental stages of schistosomes.Parasitol Res. 2011 Dec;109(6):1501-7. doi: 10.1007/s00436-011-2670-3. Epub 2011 Oct 8. Parasitol Res. 2011. PMID: 21984370 Review.
-
Tissue Degeneration following Loss of Schistosoma mansoni cbp1 Is Associated with Increased Stem Cell Proliferation and Parasite Death In Vivo.PLoS Pathog. 2016 Nov 3;12(11):e1005963. doi: 10.1371/journal.ppat.1005963. eCollection 2016 Nov. PLoS Pathog. 2016. PMID: 27812220 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources